18.07.2025 • NewsIneosinvestmentHydrogen

Ineos Invests £30 Million to Slash Emissions at Hull Site by 75%

Ineos has completed a major £30 million (€34.6 million) investment at its Hull manufacturing site, converting the facility to run on clean-burning hydrogen instead of natural gas. This results in a 75% cut in carbon emissions – the equivalent of taking around 160,000 petrol cars off the road. This advances Ineos’ net-zero commitment, well ahead of the 2050 target.

Worker at the Hull facility
This investment will deliver a transformational step change improvement in the site’s product carbon footprint.
© Ineos

The investment is part of Ineos’ wider strategy to decarbonise its operations across the UK and Europe. Ineos Acetyls is the only industrial-scale manufacturer of acetic acid, acetic anhydride, and ethyl acetate in Europe. These products are essential chemicals used in everyday life, from medicines to clean water, and the Saltend-based site now operates with dramatically lower emissions thanks to the switch to hydrogen.

David Brooks, CEO, Ineos Acetyls, said: “We’ve put £30 million into Hull to do the right thing – cut emissions, clean up the site, and future-proof our operations. We’ve slashed CO2 by 75%. That’s not a plan. That’s a result."

This investment will deliver a transformational step change improvement in the site’s product carbon footprint, which is already world-leading.

The hydrogen used at the site is produced as a co-product from existing manufacturing processes, making it a smart, efficient use of resources already on hand. It’s a model Ineos believes can be replicated across the industry.

David Brooks
David Brooks, CEO, Ineos Acetyls
© Ineos

“We’re not waiting for 2050. We’re doing it now.”

David Brooks, CEO, Ineos Acetyls

The Hull upgrade is one of several major decarbonisation projects underway across Ineos sites, including Grangemouth and Köln, as the company pushes hard to meet – and beat – its climate targets.

Ineos Acetyls employs more than 500 people worldwide. In Hull, it directly employs more than 300 people, supporting hundreds more through its supply chain.

Company

Logo:

Ineos

38 Hans Crescent, Knightsbridge
SW1X 0LZ London
UK

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.